BIT 6.67% 3.2¢ biotron limited

$10 Billion Deal, page-2732

  1. 19,063 Posts.
    lightbulb Created with Sketch. 5871
    The company has been saying exactly the same thing since 2011. Have any of you rusted-ons gone back and read the old threads?

    If BIT was in serious negotiations with anyone they would not be at BIO19 and they would be spending a fortune on lawyers and advisors. They would not be pushing their early stage pre-clinical screen program along with 10,000 other desperate biotechs.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.